01052nas a2200361   4500000000100000000000100001008004100002653001700043653002700060653003000087653002500117653002400142653002000166653002700186653002200213100001600235700001200251700001600263700001300279700001400292700001800306700001400324700001200338700001800350700001100368700001800379700001100397700001700408700001200425245022400437250001500661020001400676       2024                            d10abenchmarking10aCardiovascular disease10aElectronic Health Records10apharmacoepidemiology10aReal world evidence10atrial emulation10atrial generalizability10atrial replication1 aP. Baptiste1 aA. Wong1 aA. Schultze1 aC. Clase1 aC. Leyrat1 aE. Williamson1 aE. Powell1 aJ. Mann1 aM. Cunnington1 aK. Teo1 aS. Bangdiwala1 aP. Gao1 aL. Tomlinson1 aK. Wing00aCardiorenal effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET)  a2024/06/19  a0002-9262